US 11865166
Nucleic acid encoding optimized immunogenic peptide that targets follicle stimulating hormone receptor
granted A61KA61K2039/5256A61K2039/53
Quick answer
US patent 11865166 (Nucleic acid encoding optimized immunogenic peptide that targets follicle stimulating hormone receptor) held by Inovio Pharmaceuticals, Inc. expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inovio Pharmaceuticals, Inc.
- Grant date
- Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/5256, A61K2039/53, A61K2039/572, A61K2039/892